Results from recent clinical trials and studies in animals suggest that a class of anti-cancer drugs called angiogenesis inhibitors may be able to temporarily reduce interstitial pressure and improve the efficacy of chemotherapy and radiation treatments. (sciencedaily.com)
Before his death, Folkman began to explore treatments with angiogenesis inhibitors for conditions as seemingly disparate as myocardial infarction, diabetes, macular degeneration, and even obesity [4]. (sciencemag.org)
Bevacizumab, the first angiogenesis inhibitor approved by the FDA, is in use now to treat colon cancer. (discovermagazine.com)